Bioter Sa Stock Fundamentals
| BIOT Stock | EUR 0.29 0.03 9.38% |
Bioter SA fundamentals help investors to digest information that contributes to Bioter SA's financial success or failures. It also enables traders to predict the movement of Bioter Stock. The fundamental analysis module provides a way to measure Bioter SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioter SA stock.
Bioter |
Bioter SA Company Shares Outstanding Analysis
Bioter SA's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Bioter SA Shares Outstanding | 16.73 M |
Most of Bioter SA's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bioter SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Bioter SA has 16.73 M of shares currently outstending. This is 89.72% lower than that of the Industrial Goods sector and 90.18% lower than that of the General Contractors industry. The shares outstanding for all Greece stocks is 97.07% higher than that of the company.
Bioter SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bioter SA's current stock value. Our valuation model uses many indicators to compare Bioter SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioter SA competition to find correlations between indicators driving Bioter SA's intrinsic value. More Info.Bioter SA is rated second in return on asset category among its peers. It also is rated second in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioter SA's earnings, one of the primary drivers of an investment's value.Bioter Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bioter SA's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bioter SA could also be used in its relative valuation, which is a method of valuing Bioter SA by comparing valuation metrics of similar companies.Bioter SA is currently under evaluation in shares outstanding category among its peers.
Bioter Fundamentals
| Return On Asset | -0.0136 | |||
| Operating Margin | (7.66) % | |||
| Current Valuation | 166.03 M | |||
| Shares Outstanding | 16.73 M | |||
| Shares Owned By Insiders | 41.74 % | |||
| Price To Earning | (0.07) X | |||
| Price To Sales | 17.36 X | |||
| Revenue | 241 K | |||
| Gross Profit | (935 K) | |||
| EBITDA | (1.76 M) | |||
| Net Income | (8.81 M) | |||
| Cash And Equivalents | 255 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 143.2 M | |||
| Current Ratio | 0.18 X | |||
| Book Value Per Share | (6.07) X | |||
| Cash Flow From Operations | (6.38 M) | |||
| Earnings Per Share | 0.36 X | |||
| Beta | 0.46 | |||
| Market Capitalization | 5.82 M | |||
| Total Asset | 100 M | |||
| Retained Earnings | (109 M) | |||
| Working Capital | (97 M) | |||
| Current Asset | 36 M | |||
| Current Liabilities | 133 M | |||
| Z Score | -1.4 |
About Bioter SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioter SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioter SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioter SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Bioter S.A. operates as a construction company in Greece and internationally. The company was founded in 1962 and is based in Athens, Greece. BIOTER S is traded on Athens Stock Exchange in Greece.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bioter Stock Analysis
When running Bioter SA's price analysis, check to measure Bioter SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioter SA is operating at the current time. Most of Bioter SA's value examination focuses on studying past and present price action to predict the probability of Bioter SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioter SA's price. Additionally, you may evaluate how the addition of Bioter SA to your portfolios can decrease your overall portfolio volatility.